Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

598 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Assessing EGFR mutations.
Marchetti A, Felicioni L, Buttitta F. Marchetti A, et al. N Engl J Med. 2006 Feb 2;354(5):526-8; author reply 526-8. doi: 10.1056/NEJMc052564. N Engl J Med. 2006. PMID: 16452569 No abstract available.
EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment.
Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T, Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F. Marchetti A, et al. J Clin Oncol. 2005 Feb 1;23(4):857-65. doi: 10.1200/JCO.2005.08.043. J Clin Oncol. 2005. PMID: 15681531
K-ras mutations and cetuximab in colorectal cancer.
Marchetti A, Gasparini G. Marchetti A, et al. N Engl J Med. 2009 Feb 19;360(8):833-4; author reply 835-6. doi: 10.1056/NEJMc082346. N Engl J Med. 2009. PMID: 19228630 No abstract available.
Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones.
Marchetti A, Milella M, Felicioni L, Cappuzzo F, Irtelli L, Del Grammastro M, Sciarrotta M, Malatesta S, Nuzzo C, Finocchiaro G, Perrucci B, Carlone D, Gelibter AJ, Ceribelli A, Mezzetti A, Iacobelli S, Cognetti F, Buttitta F. Marchetti A, et al. Neoplasia. 2009 Oct;11(10):1084-92. doi: 10.1593/neo.09814. Neoplasia. 2009. PMID: 19794967 Free PMC article.
Recommendations for mutational analysis of EGFR in lung carcinoma.
Marchetti A, Normanno N; AIOM - SIAPEC-IAP, Pinto C, Taddei GL, Adamo V, Ardizzoni A, Botti G, Bardelli A, Comin C, Crinò L, Fontanini G, Gambacorta M, Marchetti A, Murer B, Normanno N, Nappi O; Italian Association of Medical Oncology; Italian Society of Anatomic Pathology and Diagnostic Cytopathology. Marchetti A, et al. Pathologica. 2010 Jun;102(3):119-26. Pathologica. 2010. PMID: 21171518 English, Italian. No abstract available.
Complex mutations & subpopulations of deletions at exon 19 of EGFR in NSCLC revealed by next generation sequencing: potential clinical implications.
Marchetti A, Del Grammastro M, Filice G, Felicioni L, Rossi G, Graziano P, Sartori G, Leone A, Malatesta S, Iacono M, Guetti L, Viola P, Mucilli F, Cuccurullo F, Buttitta F. Marchetti A, et al. PLoS One. 2012;7(7):e42164. doi: 10.1371/journal.pone.0042164. Epub 2012 Jul 27. PLoS One. 2012. PMID: 22848739 Free PMC article.
Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.
Marchetti A, Del Grammastro M, Felicioni L, Malatesta S, Filice G, Centi I, De Pas T, Santoro A, Chella A, Brandes AA, Venturino P, Cuccurullo F, Crinò L, Buttitta F. Marchetti A, et al. PLoS One. 2014 Aug 19;9(8):e103883. doi: 10.1371/journal.pone.0103883. eCollection 2014. PLoS One. 2014. PMID: 25137181 Free PMC article. Clinical Trial.
Reliability and reproducibility among different platforms for tumour BRCA testing in ovarian cancer: a study of the Italian NGS Network.
Fumagalli C, Guerini-Rocco E, Buttitta F, Iapicca P, You W, Mauri M, Felicioni L, Troncone G, Malapelle U, Scarpa A, Zamboni G, Calistri D, Barberis M, Marchetti A. Fumagalli C, et al. Among authors: marchetti a. J Clin Pathol. 2021 Oct;74(10):668-672. doi: 10.1136/jclinpath-2020-206800. Epub 2020 Oct 5. J Clin Pathol. 2021. PMID: 33020174
598 results